Need Help?

Assessment of genomic copy number alterations in breast cancer

The aim of this study was to assess genomic copy number alterations in a panel of breast cancer cell lines. These data were used to identify common aberrations associated with breast cancer, and also to identify aberrations associated with response to therapeutic compounds.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00010000490 Affymetrix 6.0- 19
Publications Citations
Modeling precision treatment of breast cancer.
Genome Biol 14: 2013 R110
179
A community effort to assess and improve drug sensitivity prediction algorithms.
Nat Biotechnol 32: 2014 1202-1212
351
Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
Nat Commun 8: 2017 1126
30
More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens.
Pharmacol Ther 191: 2018 178-189
19